Principles of Drug Development in Transplantation and Autoimmunity: Vol I (Medical Intelligence Unit) - Tapa dura
Sinopsis
This work covers the ongoing revolution in immunology, biotechnology and the regulatory science of drug development. Topics include the molcular mechanisms of approved immunomodulators (tacrolimus, mycophenolate mofetil), induction of tolerance by donor-specific cell therapy and oral antigenic tolerization to genetically engineered cell translpants for diabetes and parkinsonism. The book also covers animal models, clinical pharmacology, practical issues in trial design and analysis, and the status of promising new agents to pharmo-economic principles of drug marketing. It offers a guide for taking new molecule or recombinant DNA peptide from concept, discovery, and preclinical research to clinical evaluation and post-marketing surveillance.
"Sinopsis" puede pertenecer a otra edición de este libro.
Reseña del editor
This book is about an ongoing revolution in immunology, biotechnology and the emerging regulatory science of drug development. Its topics include the molecular mechanisms of recently approved immunomodulators (tacrolimus, mycophenolate mofetil), induction of tolerance by donor-specific cell therapy and oral antigenic tolerization to genetically engineered cell transplants for diabetes and parkinsonism. The book also covers animal models, clinical pharmacology, practical issues in trial design and analysis, current status of promising new agents to pharmaco-economic principles of drug marketing. It provides a guide for taking a new molecule or recombinant DNA peptide from concept, discovery and preclinical research to clinical evaluation and postmarketing surveillance.
Reseña del editor
This work covers the ongoing revolution in immunology, biotechnology and the regulatory science of drug development. Topics include the molcular mechanisms of approved immunomodulators (tacrolimus, mycophenolate mofetil), induction of tolerance by donor-specific cell therapy and oral antigenic tolerization to genetically engineered cell translpants for diabetes and parkinsonism. The book also covers animal models, clinical pharmacology, practical issues in trial design and analysis, and the status of promising new agents to pharmo-economic principles of drug marketing. It offers a guide for taking new molecule or recombinant DNA peptide from concept, discovery, and preclinical research to clinical evaluation and post-marketing surveillance.
"Sobre este título" puede pertenecer a otra edición de este libro.
